DOCSLIB.ORG

The Henry Kunkel Society Annual Meeting: Infectious Disease Susceptibility and the Expanding Universe of Primary Immunodeficiency

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Henry Kunkel Society Annual Meeting: Infectious Disease Susceptibility and the Expanding Universe of Primary Immunodeficiency The Henry Kunkel Society Annual Meeting: Infectious Disease Susceptibility and the Expanding Universe of Primary Immunodeficiency The Rockefeller University New York, NY April 17–20, 2013 Henry George Kunkel 1916–1983 enry Kunkel received his B.S. degree from Princeton and his M.D. degree from Johns Hopkins University. He arrived at The Rockefeller Institute (now University) in 1945 where he spent his entire scientific career H until his death in 1983. His contributions to the field of basic and clinical immunology are legendary. He made numerous seminal observations in liver disease, rheumatic diseases and other allied disorders. He was perhaps best known for his pioneering and extensive studies on the immunoglobulins. His recognition that myeloma proteins were a model for the study of the structure of normal immunoglobulins had a global impact on investigations of the structure, function and inheritance of these molecules. The elucidation of the chain structure of gamma globulin and the recognition that immunoglobulins possessed individual antigenic specificity (idiotypes) were internationally recognized discoveries. Dr. Kunkel was the recipient of many awards and honors, including membership in the National Academy of Sciences, honorary degrees from Universities of Uppsala and Harvard, and recipient of the Lasker and Gairdner Awards and the Kovalenko Medal of the National Academy of Sciences. Henry Kunkel Society Officers Henry Kunkel Society Lecturers President ................Westley Reeves 1992. Louis Kunkel 2003. .Fred Rosen Vice President ...............Keith Elkon 1993. .David Ho 2004. .Diane Mathis Secretary ........... Michel Nussenzweig 1994. Benvenuto Pernis 2005. Charles Weissman Treasurer ...............Anne Marshak- 1996. Jeffrey Ravetch 2006. Ralph M. Steinman Rothstein 1997. Anthony Fauci 2007. Antonio Lanzavecchia 1998. Klaus Rajewsky 2008. John Atkinson 1999. .Peter Doherty 2009. Thomas Tuschl 2000. Max D. Cooper 2010. Frederick Alt 2001. Fritz Melchers 2011. Mark M. Davis 2002. Tasuku Honjo 2012. .Louis M. Staudt Henry Kunkel Society Members Sergio Abrignani Ira Berkower Michael Centola Rajendra Damle Luciano Adorini Robert D. Bigler, II Anthony Cerami Franco Dammacco Vincent Agnello Richard S. Blumberg Andrea Cerutti Robert B. Darnell Irma Airold Linda K. Bockenstedt Ethel Cesarman Anne Davidson Arne N. Akbar Bjarne Bogen Edward K. L. Chan Randall S. Davis Donato Alarcon-Segovia# Stefano Bombardieri Andrew Chan Noorbibi K. Day Matthew Albert Constantin A. Bona George K. Chandy Jean-Michel Dayer Mara Luisa (Marisa) Alegre Jerry Boss† Lucienne Chatenoud Silvia Deaglio Konstantina Alexandropoulos† Marina Botto Talal Chatila Paolo Dellabona Paul Allen† Vassiliki A. Boussiotis† Triantafyllos Chavakis Stephen V. Desiderio Chester A. Alper Jean-Pierre Bouvet Youhai Chen Kavita Dhodapkar Sebastian Amigorena Joseph Boyle Selina Chen-Kiang Madhav V. Dhodapkar Ulf Anderson Thomas J. Braciale Nicholas Chiorazzi Betty A. Diamond Paul J. Anderson Ferdinand C. Breedveld Francis V. Chisari Howard Dickler Francesco Annuziato Michael Brenner Carlo Chizzolini Guillermo Dighiero William P. Arend Stanley Louis Bridges Charles Christian Teresa P. DiLorenzo Joseph R. Arron Thomas Brocker Charles Chu Walter H. Doerfler John P. Atkinson Eric Brown Marcus Ramsay Clark Peter C. Doherty K. Frank Austen Teodor-Boru Brumeanu Edward A. Clark Thomas Dörner Stratis Avrameas Gerd-Rudiger Burmester Charles Cochrane Daniel Douek Raffaele Badolato Joel Buxbaum Richard Coico Steven Douglas David Bahler Jill Buyon Mary Ellen Conley Terry William Du Clos Vincenzo Barnaba John C. Byrd Gabriela Constantin Anne Durandy Craig Bassing Michael Cahalan H. Terence Cook George Ebers Antony Basten Federico Caligaris-Cappio David Cooper Dimitar G. Efremov Ekkehard K. F. Bautz Michael P. Cancro Max D. Cooper Michael Ehrenstein Alexander Bearn# Daniela Capello Andrew P. Cope Götz Ehrhardt Timothy W. Behrens J. Donald Capra Joseph Craft Klaus Eichmann Baruj Benacerraf# Ronald I. Carr Carlo M. Croce Robert A. Eisenberg J. Claude Bennett Michael C. Carroll Alan Cross Hani El-Gabalawy Christophe O. Benoist Robert H. Carter Mary K. Crow Keith Elkon Zvi Bentwich Paolo Casali Charlotte Cunningham- Anna Erdei† Claudia Berek Jean-Laurent Casanova Rundles Doruk Erkan Kâre Berg Rafael Casellas Riccardo Dalla-Favera Luis R. Espinoza Paul Evans Richard J. Hodes Lloyd Mayer Marko Z. Radic Norman Talal Zsuzsa Fabry V. Michael Holers Maclyn McCarty# Kanti R. Rai Eng M. Tan Andras Falus Steven M. Holland James McCluskey Klaus Rajewsky Stuart Tangye Donna L. Farber Halsted R. Holman Joseph (Mike) McCune Joyce Rauch Alexander Tarakhovsky A. Darise Farris David Horn A. McGehee Harvey Jeffrey Ravetch Kristin Tarbell C. Garrison Fathman Alan N. Houghton Victor McKusick Stanley Read Naomi Taylor Douglas Thomas Fearon Thomas W. J. Huizinga Ruslan Medzhitov Ann Reed Francesco Tedesco Ten Feizi Mary Beth Humphrey Eric Meffre Westley H. Reeves Cox Terhorst Marc Feldmann John Hurley# Fritz Melchers Morris Reichlin Argyrios N. Theofilopoulos Gianfranco Ferraccioli David A. Isenberg Elizabeth D. Mellins Bernardo Reina- Robert Thoburn Manlio Ferrarini Kimishige Ishizaka Henri Menard San Martin Adrian Thrasher Erol Fikrig Lionel B. Ivashkiv Miriam Merad Maria Rescigno Angela Tincani Terri Finkel Bana Jabri Pier Luigi Meroni Michael Reth Thomas Tomasi Alison Finnegan Hans-Martin Jäck Joan T. Merrill Lisa G. Rider Kevin J. Tracey Gary S. Firestein Chaim Oscar Jacob Jiri Mestecky Frederic Rieux-Laucat Elisabetta Traggiai Vincent Fischetti Israeli Jaffe Christine Metz William C. Robbins Edward L. Treadwell Zvi Fishelson Ashish Jain† Dror Mevorach William Robinson Giorgio Trinchieri David E. Fisher Judith A. James Mary Ann Michelis Toby Rodman Jurg Tschopp# Richard A. Flavell Roland Jonsson Peter A. Miescher Martin Rodriguez George Tsokos Thomas A Fleisher Dieter Kabelitz Fred Miller Santiago Rodriguez Naoyuki Tsuchiya Ira J. Fox Joachim R. Kalden Eric C. B. Milner de Cordoba Shannon Turley Marvin Fritzler Insoo Kang Toshihide Mimura Axel Roers Antonio Uccelli Yang-Xin Fu Fu Gilla Kaplan Seiji Minota Lars Rönnblom Jonathan W. Uhr Shu Man Fu Mikael Karlsson Pierre Miossec† Antony Rosen Raivo Uibo Herman Fudenberg Jonathan D. Katz Chandra Mohan Fred Rosen# Emil R. Unanue Sarah L. Gaffen Michel D. Kazatchkine Tom Eirik Mollnes Agueda A. Rostagno Derya Unutmaz Patrick Gaffney Jack D. Keene Patricia K. A. Mongini Thomas Rothstein Jacques Urbain Gianluca Gaidano Robert Kimberly Laurence Morel Robert A. S. Roubey Paul J. Utz Thomas F. Gajewski Paul W. Kincade Lorenzo Moretta Robert L. Rubin Anders G. Vahlne Uri Galili Thomas Kindt Jane Morse# Alexander Y. Rudensky Andrea Vambutas Ignacio Garcia- Te Piao King Bernard Moser Carlo Russo Wesley C. Van Voorhis De La Torre Michael Kirschfink William A. Muller Federica Sallusto Charles S. Via Hubert Baburaj (Bobby) Lars Klareskog Hans Muller-Eberhard# Jane E. Salmon Anna Villa Gasper† Kim L. Kline Kenneth Murphy Hugh A. Sampson Herbert W. Virgin Raif S. Geha Glen Knight Philip M. Murphy Inger Sandlie Ulrich H. Freiherr James L. German, III Daniel M. Knowles Natarajan Muthusamy Matyas Sandor von Andrian-Werburg M. Eric Gershwin Hon-Sum Ko Bertrand Nadel Laura Santambrogio Harald von Boehmer Paolo Ghia Alisa E. Koch Carl F. Nathan Ignacio Sanz Takaji Wakita Allan Gibofsky David Koffler# Jacob B. Natvig Minoru Satoh Thomas A. Waldmann Irma Gigli Frits Koning Gerald Thomas Nepom David Schatz† Herman Waldmann Gray Steven Gilkeson Dwight H. Kono Janko Nikolich-Zugich Georg Schett Mark Jeremy Walport Martin John Glennie Philippe H. A. Kourilsky Kenneth Nilsson Claudine Schiff Chang-Yi Wang Laurie Glimcher Michael Krangel Falk Nimmerjahn Reinhold Schmidt† Jingsong Wang Otto Goetze Richard Krause Douglas F. Nixon Robert Schreiber† H. Shaw Warren Leslie Gold Karsten Kretschmer† Gustav J. V. Nossal Harry W. Schroeder, Jr. Richard L. Wasserman Raphaela Goldbach- James G. Krueger Luigi D. Notarangelo Peter H. Schur Martin Weigert Mansky Vijay Kuchroo Jan Novak R. Hal Scofield Jean-Claude Weill† Robert A. Good# Dinakantha Kumararatne Victor Nussenzweig Gavin Screaton Marc Weksler Tom Gordon Steven Kunkel Michel C. Nussenzweig Benjamin M. Segal Hans Ulrich Weltzien Siamon Gordon Louis Kunkel Hans D. Ochs Andrey Shaw† Peter P. Wernet Jorg J. Goronzy Antonio La Cava Lloyd Old Barbaray Sherry Per Westermark Emil C. Gotschlich Peter J. Lachmann Michael B. A. Oldstone Yufang Shi Cornelia M. Weyand Susan R. S. Gottesman Robert G. Lahita Eugene Oltz Mark Jay Shlomchik Juergen Wienands Alice B. Gottlieb Antonio Lanzavecchia Jordan Scott Orange† Frederick P. Siegal David Wiest† Ellen M. Gravallese Terri Laufer Anders Orn Leslie E. Silberstein Ralph C. Williams, Jr. Arthur Grayzel Jeffery A. Ledbetter Barbara Anne Osborne Gregg Silverman Patrick C. Wilson Mark Grebenau David M. Lee C. Kirk Osterland Roy L. Silverstein Robert J. Winchester Mark I. Greene Paul J. Lehner Mario A. Ostrowski Franco Silvestris John Winfield Howard M. Grey Beth Levine Shoichi Ozaki Alfred Singer Jedd Wolchok Bodo Grimbacher Peter Lipsky Stephen A. Paget Ram Singh Kevin Woollard† Luca Guidotti Sergio A. Lira Savita Pahwa Francesco Sinigaglia Kai W. Wucherpfennig Sudhir Gupta Gary W. Litman Eric G. Pamer John Patrick Sissons Ramnik Xavier David A. Hafler Stephen Litwin Sunpho Park Marjorie Slankard Kazuhiko Yamamoto Kathleen A. Haines Yang Liu Virginia Pascual Barry Sleckman William Yount William W. Hall Miguel Lopez-Botet Dhavalkumar D. Patel Kendall Smith John Zabriskie Lars Hanson Pier Luigi Luigi
Load more

Recommended publications
  • Differential Synergy of Notch and T Cell Receptor Signaling Determines Αβ
    ARTICLE Diff erential synergy of Notch and T cell receptor signaling determines αβ versus γδ lineage fate Annette I. Garbe,1 Andreas Krueger,1 Fotini Gounari,1,2 Juan Carlos Zúñiga-Pfl ücker,3 and Harald von Boehmer1 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 2Tufts-New England Medical Center, Boston, MA 02111 3University of Toronto, Toronto, Ontario, M4N 3M5 Canada Thymic precursors expressing the pre–T cell receptor (TCR), the TCR, or the TCR can all enter the CD4+8+ lineage, albeit with different effi cacy. Here it is shown that proliferation and differentiation of precursors with the different TCRs into lineage cells require Notch signaling at the DN3 stage of thymic development. At the DN4 stage, Notch signaling still signifi cantly contributes to the generation of T cells. In particular, in lineage commitment, the pre-TCR synergizes more effi ciently with Notch signals than the other two TCRs, whereas TCR-expressing cells can survive and expand in the absence of Notch signals, even though Notch signaling enhances their proliferation. These observations suggest a new model of versus lineage choice in which lineage fate is determined by the extent of synergy between TCR and Notch signaling and in which the evolutionarily recent advent of the cell-autonomously signaling pre-TCR increased the effi cacy of T cell generation. CORRESPONDENCE The mammalian immune system contains sev- essential for the rescue of DP cells from pro- Harald von Boehmer: eral T lymphocyte lineages of which the grammed cell
    [Show full text]
  • Deciphering Thymic Development
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE OPINION ARTICLE published: 08provided October by 2014 Frontiers - Publisher Connector doi: 10.3389/fimmu.2014.00424 Deciphering thymic development Harald Von Boehmer 1,2* 1 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA 2 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, USA *Correspondence: [email protected] Edited by: Kendall A. Smith, Weill Medical College of Cornell University, USA Reviewed by: Herman Waldmann, University of Oxford, UK Keywords: MHC-restricted antigen recognition, T cell clones, TCR alpha/beta cDNA clones, HY antigen, TCR transgenic mice, negative thymic selection, positive thymic selection In 1979, some of us were surprised by beta genes from one T cell clone to asked Hans Georg Rammensee who was the (1) conclusion of Doherty and Zinker- another allowed us to unequivocally con- in the same office a related question. I nagel on MHC-restricted antigen recogni- clude that the MHC-restricted specificity leave it to the audience to imagine what tion following the lead of Katz, Hamaoka, was encoded by a single receptor long Michael Steinmetz told Georges Koehler and Benacerraf (2) describing the same before crystallographic studies reached or better what he did not tell him, even for the interaction of T helper cells with the same conclusion (5). This surprised though one cannot be completely sure of B cells as well as Rosenthal and Shevach some molecular biologists somewhat who it. So Georges did not produce the mice (3) describing it for the interaction of T thought that the cloning of the TCR put but Anton Berns in Amsterdam cooper- cells with macrophages.
    [Show full text]
  • Mucosal Immunity
    Mucosal Immunity Lloyd Mayer, MD ABSTRACT. Food allergy is the manifestation of an antibody, secretory immunoglobulin A (sIgA), which abnormal immune response to antigen delivered by the is highly suited for the hostile environment of the gut oral route. Normal mucosal immune responses are gen- (Fig 1). All of these in concert eventuate in the im- erally associated with suppression of immunity. A nor- munosuppressed tone of the gastrointestinal (GI) mal mucosal immune response relies heavily on a num- tract. Defects in any individual component may pre- ber of factors: strong physical barriers, luminal digestion dispose to intestinal inflammation or food allergy. of potential antigens, selective antigen sampling sites, and unique T-cell subpopulations that effect suppres- sion. In the newborn, several of these pathways are not MUCOSAL BARRIER matured, allowing for sensitization rather than suppres- The mucosal barrier is a complex structure com- sion. With age, the mucosa associated lymphoid tissue posed of both cellular and noncellular components.5 matures, and in most individuals this allows for genera- Probably the most significant barrier to antigen entry tion of the normal suppressed tone of the mucosa asso- into the mucosa-associated lymphoid tissue (MALT) ciated lymphoid tissue. As a consequence, food allergies are largely outgrown. This article deals with the normal is the presence of enzymes starting in the mouth and facets of mucosal immune responses and postulates how extending down to the stomach, small bowel, and the different processes may be defective in food-allergic colon. Proteolytic enzymes in the stomach (pepsin, patients. Pediatrics 2003;111:1595–1600; gastrointestinal papain) and small bowel (trypsin, chymotrypsin, allergy, food allergy, food hypersensitivity, oral tolerance, pancreatic proteases) perform a function that they mucosal immunology.
    [Show full text]
  • Table of Contents
    Cancer Immunology Research Table of Contents July 2014 Volume 2 Issue 7 EDITORIAL RESEARCH ARTICLES 591 Cancer Immunology Research: A One-Year 616 Immunotherapy Converts Nonimmunogenic Anniversary Pancreatic Tumors into Immunogenic Foci of Immune Regulation Eric R. Lutz, Annie A. Wu, Elaine Bigelow, Rajni Sharma, Guanglan Mo, Kevin Soares, Sara Solt, MASTERS OF IMMUNOLOGY Alvin Dorman, Anthony Wamwea, Allison Yager, Daniel Laheru, Christopher L. Wolfgang, 592 The Thymus in Immunity and in Malignancy Jiang Wang, Ralph H. Hruban, Robert A. Anders, Harald von Boehmer Elizabeth M. Jaffee, and Lei Zheng Synopsis: Lutz and colleagues show that an allogeneic vaccine given with or without low-dose cyclophosphamide converted pancreatic cancer into an immunogenic cancer CANCER IMMUNOLOGY AT THE with infiltrating effector lymphocytes and formation of CROSSROADS: EXPERIMENTAL tertiary lymphoid aggregates that are regulatory structures IMMUNOTHERAPIES of adaptive immunity. 632 598 Hostile, Hypoxia–A2-Adenosinergic Tumor Bevacizumab plus Ipilimumab in Patients with Biology as the Next Barrier to Overcome for Metastatic Melanoma Tumor Immunologists F. Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Michail V. Sitkovsky, Stephen Hatfield, Anita Giobbie-Hurder, Michael B. Atkins, Robert Abbott, Bryan Belikoff, Dmitriy Lukashev, Nageatte Ibrahim, Philip Friedlander, and Akio Ohta Keith T. Flaherty, George F. Murphy, Scott Rodig, Elsa F. Velazquez, Martin C. Mihm Jr, Sara Russell, MILESTONES IN CANCER
    [Show full text]
  • Mucosal Immunity
    Mucosal Immunity Lloyd Mayer, MD ABSTRACT. Food allergy is the manifestation of an antibody, secretory immunoglobulin A (sIgA), which abnormal immune response to antigen delivered by the is highly suited for the hostile environment of the gut oral route. Normal mucosal immune responses are gen- (Fig 1). All of these in concert eventuate in the im- erally associated with suppression of immunity. A nor- munosuppressed tone of the gastrointestinal (GI) mal mucosal immune response relies heavily on a num- tract. Defects in any individual component may pre- ber of factors: strong physical barriers, luminal digestion dispose to intestinal inflammation or food allergy. of potential antigens, selective antigen sampling sites, and unique T-cell subpopulations that effect suppres- sion. In the newborn, several of these pathways are not MUCOSAL BARRIER matured, allowing for sensitization rather than suppres- The mucosal barrier is a complex structure com- sion. With age, the mucosa associated lymphoid tissue posed of both cellular and noncellular components.5 matures, and in most individuals this allows for genera- Probably the most significant barrier to antigen entry tion of the normal suppressed tone of the mucosa asso- into the mucosa-associated lymphoid tissue (MALT) ciated lymphoid tissue. As a consequence, food allergies are largely outgrown. This article deals with the normal is the presence of enzymes starting in the mouth and facets of mucosal immune responses and postulates how extending down to the stomach, small bowel, and the different processes may be defective in food-allergic colon. Proteolytic enzymes in the stomach (pepsin, patients. Pediatrics 2003;111:1595–1600; gastrointestinal papain) and small bowel (trypsin, chymotrypsin, allergy, food allergy, food hypersensitivity, oral tolerance, pancreatic proteases) perform a function that they mucosal immunology.
    [Show full text]
  • Defective Expression of Gp180, a Novel CD8 Ligand on Intestinal Epithelial Cells, in Inflammatory Bowel Disease
    Defective Expression of gp180, a Novel CD8 Ligand on Intestinal Epithelial Cells, in Inflammatory Bowel Disease Lisa S. Toy,*‡ Xian Yang Yio,* Annica Lin,* Shaun Honig,* and Lloyd Mayer* *Division of Clinical Immunology and the ‡Dr. Henry D. Janowitz Division of Gastroenterology, Mount Sinai Medical Center, New York 10029 Abstract active inflammation in an organ where controlled inflamma- tion is the norm. Work from several laboratories has sup- Previous studies support a role for intestinal epithelial cells ported the concept that this active inflammatory process is the (IEC) as antigen-presenting cells in mucosal immune re- result of a dysregulated immune response. More specifically, sponses. T cells activated by IEC are CD8ϩ, suppressor in there is evidence of constitutively activated CD4ϩ T cells function, and dependent upon CD8-associated p56lck acti- within the lamina propria that can leak into the systemic circu- vation. A 180-kD glycoprotein (gp180) recognized by mAbs lation (1, 2). These activated CD4ϩ T cells secrete a panel of B9 and L12 has been identified and shown to be important cytokines that may promote localized cell-mediated granulo- in CD8ϩ T cell activation by IEC. Since IEC derived from matous inflammation (CD) (3–6) or a more diffuse antibody- patients with inflammatory bowel disease (IBD) are incapa- and complement-mediated Arthus-type reaction (UC) (7, 8). ble of activating CD8ϩ T cells, we asked whether this corre- While many pathogenetic mechanisms have been proposed to lated with gp180 expression. While frozen sections of nor- explain these observations, to date no consistent infectious, mal bowel revealed bright gp180 staining on all IEC, both neurohormonal, or immunologic mechanism has been eluci- inflamed and uninflamed ulcerative colitis (UC) specimens dated.
    [Show full text]
  • April 8, 1997, NIH Record, Vol. XLIX, No. 7
    C 0 R a Still The Second Best Thing About Payday Record Debuts on the Web HIGHLIGHTS· From 'Whatchamacallit' to Funshine New Camp Starts for Children The NIH Record, exclusively a paper publication since May 1949, is now Special love Infected with HIV available electronically on the World Wide launches New By Rich McManus Web. It can be accessed within the NIH Camp home page (www.nih.gov) under the nless you just came to NIH a week ago, you probably know at " Information for Employees" and "News Microsoft least something about Camp Fantastic. For the uninitiated, it's and Events" sections. Or open the site Wunderkind ~ a week-long slice of August turned into terrific summer camp directly by going to http://www.nih.gov/ Foretells Future for children-many of them Clinical Center patients-with cancer, news/NIH-Record/archives.htm. and has always been powered by the freehearted and funloving Catch the Record side of the National Cancer Institute-its Pediatric Branch and The Web version is modeled after the on the Web associated caregivers. It began 15 years ago at a 4-H campground paper one and closely resembles it, but has near Front Royal, Va., and has evolved into a year-round, family­ the advantage of color design and centered program that worries not just about the child with photography. The site's opening page is an cancer, but also about the healthy sibling who wonders where all " Archives" of issues that leads off-for the Dyer, Gorgas Talks of mom and dad's attention went.
    [Show full text]
  • Shaping the T Cell Repertoire
    Shaping the T Cell Repertoire Harald von Boehmer J Immunol 2005; 175:7067-7068; ; This information is current as doi: 10.4049/jimmunol.175.11.7067 of September 27, 2021. http://www.jimmunol.org/content/175/11/7067 Downloaded from References This article cites 6 articles, 3 of which you can access for free at: http://www.jimmunol.org/content/175/11/7067.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts Errata An erratum has been published regarding this article. Please see next page or: /content/176/1/677.1.full.pdf /content/176/1/677.2.full.pdf The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Shaping the T Cell Repertoire Harald von Boehmer1 Today immunologists are well aware of positive to self. In this hypothesis, the focus on self-MHC was imposed and negative selection of developing T cells.
    [Show full text]
  • Lack of Induction of Suppressor T Cells by Intestinal Epithelial Cells from Patients with Inflammatory Bowel Disease
    Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease. L Mayer, D Eisenhardt J Clin Invest. 1990;86(4):1255-1260. https://doi.org/10.1172/JCI114832. Research Article The mechanisms underlying the chronic unrelenting inflammatory response seen in inflammatory bowel disease (IBD) are poorly understood. We have recently proposed a novel role for the normal intestinal enterocyte, that of antigen presenting cell. However, in contrast to conventional antigen presenting cells, normal enterocytes appear to selectively activate CD8+ antigen nonspecific suppressor T cells. To determine whether failure of this process may be occurring in inflammatory bowel disease, freshly isolated enterocytes from small and large bowel from normal patients, patients with Crohn's disease, ulcerative colitis, and inflammatory (diverticulitis, ischemic colitis, and gold induced colitis) controls were co-cultured with allogeneic T cells in a modified mixed lymphocyte reaction. In contrast to normal enterocytes, 42/42 Crohn's and 35/38 ulcerative colitis-derived epithelial cells stimulated CD4+ T cells, whereas 65/66 and 9/9 normal and inflammatory control enterocytes, respectively, stimulated CD8+ T cells (as previously described), suggesting that the results seen were not just a reflection of underlying inflammation. Furthermore, IBD enterocytes from both histologically involved and uninvolved tissue were similar in their ability to selectively activate CD4+ T cells, speaking for a more global defect in
    [Show full text]
  • Harald Von Boehmer 1942–2018
    obituary Harald von Boehmer 1942–2018 oday, few topics in immunology Notch family of signaling receptors in this receive more attention than efforts malignancy. With colleagues in the lab, Tto detect, induce or reinvigorate the Harald also published important insights immune response to tumors. Although into the mechanisms through which many types of immune cells affect different T cell populations respond to and contribute to anti-tumor immune tumors and destroy pancreatic β -cells. At responses, the initial clinical findings that the same time, he never stopped pursuing electrified the field focused on the T cell. knowledge of the basic mechanisms that Cancer biologists who grabbed the nearest affect T cell development. While in Boston, immunology textbook in an effort to fully his lab described mechanisms that affect comprehend and build upon those initial the development of regulatory T cells in the clinical successes will have quickly realized thymus and the periphery and continued that at their core, such approaches rely on to publish insights into the structure and understanding how T cells recognize and function of the pre-TCR. respond to antigen. What they may not After closing his Boston lab, Harald have realized is how important Harald returned to his alma mater as a guest von Boehmer’s work was in laying the professor at the Institute for Immunology foundation for this understanding. of the Ludwig Maximilian University in Long before translational research was Munich. In his writings during this period, all the rage, Harald charged a segment of between the TCR and peptide–major Harald expressed optimism about the future his lab with investigating how fundamental histocompatibility complex determined of immunological research.
    [Show full text]
  • Deciphering Thymic Development
    Deciphering Thymic Development The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Von Boehmer, Harald. 2014. “Deciphering Thymic Development.” Frontiers in Immunology 5 (1): 424. doi:10.3389/fimmu.2014.00424. http://dx.doi.org/10.3389/fimmu.2014.00424. Published Version doi:10.3389/fimmu.2014.00424 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:13347532 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA OPINION ARTICLE published: 08 October 2014 doi: 10.3389/fimmu.2014.00424 Deciphering thymic development Harald Von Boehmer 1,2* 1 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA 2 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, USA *Correspondence: [email protected] Edited by: Kendall A. Smith, Weill Medical College of Cornell University, USA Reviewed by: Herman Waldmann, University of Oxford, UK Keywords: MHC-restricted antigen recognition, T cell clones, TCR alpha/beta cDNA clones, HY antigen, TCR transgenic mice, negative thymic selection, positive thymic selection In 1979, some of us were surprised by beta genes from one T cell clone to asked Hans Georg Rammensee who was the (1) conclusion of Doherty and Zinker- another allowed us to unequivocally con- in the same office a related question. I nagel on MHC-restricted antigen recogni- clude that the MHC-restricted specificity leave it to the audience to imagine what tion following the lead of Katz, Hamaoka, was encoded by a single receptor long Michael Steinmetz told Georges Koehler and Benacerraf (2) describing the same before crystallographic studies reached or better what he did not tell him, even for the interaction of T helper cells with the same conclusion (5).
    [Show full text]
  • The Paul Ehrlich Foundation
    The Paul Ehrlich Foundation Office of the Paul Ehrlich Foundation Contents Paul Ehrlich-Stiftung c/o Vereinigung von Freunden und Förderern der Goethe-Universität Theodor-W.-Adorno-Platz 1 Preface 5 60629 Frankfurt am Main E-Mail: [email protected] www.paul-ehrlich-stiftung.de Paul Ehrlich: His Life March 2021 and Achievements 6 Ludwig Darmstaedter: Donation account: Scientist and Friend 12 Deutsche Bank AG IBAN: DE38 5007 0010 0700 0839 00 BIC: DEUTDEFFXXX The Foundation, the Prize and the Role of Hedwig Ehrlich 14 The Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers 17 Preface In honor of the great German doctor and Paul Ehrlich, like all great researchers, was serologist who turned Frankfurt into a way ahead of his time. His research work medical eldorado at the beginning of the laid the cornerstone for the medical stand- 20th century, the Paul Ehrlich and Ludwig ards still valid today. In awarding the Paul Darmstaedter Prize is awarded to scientists Ehrlich and Ludwig Darmstaedter Prize, the from all over the world who have achieved Foundation wishes to encourage scientists all outstanding results in Paul Ehrlich’s field over the world to do what Paul Ehrlich did of work. throughout his entire life: extend medical know-how and make a contribution to the The prize given by the Paul Ehrlich constant struggle against illness and disease- Foundation is one of Germany’s most emi- induced mortality. nent accolades in recognition of outstand- ing achievements in biomedical research. The President of the German Research Foundation (DFG) is Honorary President of the Paul Ehrlich Foundation.
    [Show full text]